The Science and Beyond at EIP Lisbon Blogs
Read article The Science and Beyond at EIP Lisbon

Last month, Elodie, Magali, and I found ourselves in Lisbon—not for a spring getaway (though the weather was a delightful preview of the season) and certainly not for ultra-trail training (although the city’s hills did give our calves a solid workout!). Instead, we were there for EIP, an event…

KCAS-podcast-thumb_TWB-086 Podcasts
Listen to podcast Podcast (The Weekly Bioanalysis) Eps #86: “Immunogenicity Discussion w/ Special Guest Cheikh Kane – What is a Lean ADA?”

During episode 86 of KCAS Bio’s “The Weekly Bioanalysis” podcast, our hosts Dom and John are joined by Dr Cheikh Kane, the Vice President of Biopharma Services at KCAS Bio, to discuss immunogenicity. They first define Immunogenicity; what it is and why it is tested, as well as the standard…

KCAS-blog-thumb_2024-011_ADA_Immunogenicity Assay Development Blogs
Read article The Critical Role of Immunogenicity in Drug Development: Why It Matters

Immunogenicity, why do we keep talking about it? Immunogenicity can, in the simplest of terms, be described as a subject’s ability to generate antibodies specific to the dosed protein therapeutic. While stating it this way understates the complexity of the immune system and the methods needed to detect and characterize…

KCAS-blog-thumb_2024-09_USevents1 Blogs
Read article KCAS Bio’s October Roadshow

KCAS Bio is excited to announce our participation in several premier conferences throughout the United States this fall. These events bring together experts, innovators, and leaders in pharmaceuticals, biotechnology, and clinical research to exchange insights, explore the latest technologies, and drive the future of scientific discovery. As a trusted provider…

KCAS-event_2024-03_EIP April 22 - April 24

The European Immunogenicity Platform (EIP) is a central meeting place for scientists and biopharmaceutical companies in Europe. The goal of the EIP is to improve knowledge and expertise in immunogenicity. This is achieved through collaboration between scientists and industry experts. The EIP works with companies, institutes, and professionals involved in…

KCAS-blog-thumb_2023-11A_immunogenicity Blogs
Read article The Role of Immune Profiling for Studying Disease & Therapy Response

Immunogenicity refers to the ability of a substance, such as an antigen or a vaccine, to provoke an immune response in an organism. The recognition of the substance as foreign triggers an immune response, which involves the production of antibodies and the activation of immune cells to fight against or…

PATTERN_BLUE_1320x780_2 Webinars
View webinar KCAS Bio Webinar – Produced by Bioanalysis Zone “Bioanalytical Considerations for Immunogenicity of Cell and Gene Therapies”

Produced by Bioanalysis Zone Recorded on December 11, 2023 Webinar available here.  Webinar Description: In this webinar, Dominic Warrino discusses the bioanalytical considerations of immunogenicity of cell and gene therapies. Bioanalysis method development and method validation of immunogenicity assays for support of cell and…

3d illustration lymphocytes, t cells or cancer cells Blogs
Read article ELISpot Assay: Versatile Applications and Common Challenges to Overcome

ELISpot (Enzyme-linked immunosorbent spot) is an immunoassay-based technique used to quantify cells that are capable of secreting proteins, including cytokines, cytotoxic molecules, and antibodies, when stimulated with the appropriate antigen. Initially designed to monitor the frequency of circulating antigen-specific memory B-cells, it is now commonly used to determine the frequency…

PATTERN_BLUE_1320x780_3 Blogs
Read article Overcoming Challenges in Bioanalytical Method Transfers

KCAS is a rapidly growing industry leader that continues to increase its vast knowledge surrounding assay transfers not only internally but externally as well.  As KCAS expands as a global leader in the bioanalytical space we have taken our knowledge surrounding internal assay transfers and extended that knowledge to external…

KCAS-blog-thumb_2023-09A_LBAs-Plethora Blogs
Read article Ligand Binding Assays: a Plethora of Technologies to Address Your Projects’ Requirements

Ligand binding assays (LBAs) have been our core activity for decades. LBAs are commonly used to measure interactions between two proteins, a ligand and its receptor, a monoclonal antibody (mAb) and its target, or biologics and Anti-Drug Antibodies (ADA). Throughout the development of New…